1. Exploratory Factor Analysis for Validating Traditional Chinese Syndrome Patterns of Chronic Atrophic Gastritis
    Yin Zhang et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
    Shyam Singh et al, 2017, Journal of Oncology CrossRef
  3. Comparative Evaluation of RUT, PCR and ELISA Tests for Detection of Infection with Cytotoxigenic H. pylori
    Farzaneh Jalalypour et al, 2016, Adv Pharm Bull CrossRef
  4. The Utilization of a New Immunochromatographic Test in Detection ofHelicobacter pyloriAntibody from Maternal and Umbilical Cord Serum
    Fu-Chen Kuo et al, 2014, BioMed Research International CrossRef
  5. Omega-3 Polyunsaturated Fatty Acids Intake to RegulateHelicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach
    Jong-Min Park et al, 2015, BioMed Research International CrossRef
  6. Correlation between CD34 Marker and Clinico-Pathologic Characteristics of Gastric Cancer
    Afshin Habibi et al, 2015, International J. of Cancer Research CrossRef
  7. Role of Chlamydia in the Development of Ocular Adnexal Lymphoma
    Carlo Contini et al, 2013, JCT CrossRef
  8. Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
    YAN-SHEN SHAN et al, 2015 CrossRef
  9. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Shiyu Xiao et al, 2017, Int J Oncol CrossRef
  10. Helicobacter pylori promotes VEGF expression via the p38 MAPK-mediated COX-2-PGE2 pathway in MKN45 cells
    NINGNING LIU et al, 2014 CrossRef
  11. Precancerous colorectal lesions
    VINCENZA CONTEDUCA et al, 2013 CrossRef
  12. Correlation between virulence markers of Helicobacter pylori in the oral cavity and gastric biopsies
    Myriam Lucrecia MEDINA et al, 2017, Arq. Gastroenterol. CrossRef
  13. MicroRNAs as potential biomarkers for gastric cancer
    Han-Shao Liu, 2014, WJG CrossRef
  14. SerumHelicobacter pyloriKatA and AhpC antibodies as novel biomarkers for gastric cancer
    Bing Zhang et al, 2016, WJG CrossRef
  15. Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer
    Hui-Ying Ma et al, 2016, WJG CrossRef
  16. Recurrence of infection and diversity of Helicobacter pylori strains in an adult population in Mexico treated with empirical standard triple therapy.
    Jaime Alberto Sánchez Cuén et al, 2017, Rev Esp Enferm Dig CrossRef
  17. High TREM2 expression correlates with poor prognosis in gastric cancer
    Xiaojing Zhang et al, 2017, Human Pathology CrossRef
  18. Propolis: The future therapy against Helicobacter pylori -mediated gastrointestinal diseases
    Ummay Mahfuza Shapla et al, 2017, Journal of Applied Biomedicine CrossRef
  19. Role of phytochemicals in the inhibition of epithelial–mesenchymal transition in cancer metastasis
    Eun-Kyung Kim et al, 2016, Food Funct. CrossRef
  20. Antimetastatic Effects of Celastrus orbiculatus on Human Gastric Adenocarcinoma by Inhibiting Epithelial–Mesenchymal Transition and NF-κB/Snail Signaling Pathway
    Yaodong Zhu et al, 2015, Integr Cancer Ther CrossRef
  21. Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data
    Xiaomei Li et al, 2017 CrossRef
  22. Inside Helicobacter Pylori: A Serious Threat to Humans
    Abdul Rehman, 2018, Avicenna J Clin Microb Infec CrossRef
  23. Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review
    CHUN CAO et al, 2014 CrossRef
  24. Expression of early growth response gene-1 in precancerous lesions of gastric cancer.
    Seon-Young Park et al, 2016, Oncol Lett CrossRef
  25. Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases
    Yao-Kuang Wang et al, 2018, Helicobacter CrossRef
  26. Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)
    Zhining Liu et al, 2018, Gastric Cancer CrossRef
  27. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer
    Jianjun Wang et al, 2018, CBM CrossRef
  28. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis
    Zhensheng Wang et al, 2018 CrossRef
  29. Global estimate of gastric cancer in Helicobacter pylori -infected population: A systematic review and meta-analysis
    Ali Pormohammad et al, 2018, J Cell Physiol CrossRef
  30. Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study
    Young-Jae Hwang et al, 2018, Korean J Helicobacter Up Gastrointest Res CrossRef
  31. Üst gastrointestinal sistem endoskopisi yapılan hastalarda intestinal metaplazi ve Helikobakter pylori skorlarının karşılaştırılması
    Uğur Kesici, 2018 CrossRef
  32. Protein changes in gastric epithelial cells RGM-1 in response to Helicobacter pylori infection
    Zengfa Lv et al, 2018, J Cell Biochem CrossRef
  33. Interleukin-6 Expression in Serum, Gastric Juice and Gastric Mucosa of Helicobacter pylori Positive Gastric Cancer Patients
    Yanglong Chen et al, 2019, International J. of Pharmacology CrossRef
  34. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis
    Anna A. Nieminen et al, 2019, Scandinavian Journal of Gastroenterology CrossRef
  35. Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis
    Kichul Yoon et al, 2019, PLoS ONE CrossRef
  36. Gastric Microbiota in Helicobacter pylori-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area
    Boldbaatar Gantuya et al, 2019, Cancers CrossRef
  37. Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study
    Zhensheng Wang et al, 2017, Br J Cancer CrossRef
  38. Gastric cancer-molecular and clinical dimensions.
    Roopma Wadhwa et al, 2013, Nat Rev Clin Oncol CrossRef
  39. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer
    Jingjing Liu et al, 2015, Sci Rep CrossRef
  40. Helicobacter pylori Genetic Diversity and Gastro-duodenal Diseases in Malaysia
    Selva Perumal Gunaletchumy et al, 2015, Sci Rep CrossRef
  41. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA
    Asako Shimoda et al, 2016, Sci Rep CrossRef
  42. null
    Charles LeVea, 2015 CrossRef
  43. The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
    Chun-Wei Chen et al, 2019, Therap Adv Gastroenterol CrossRef
  44. Salt-mediated transcriptional and proteasomal dysregulations mimic the molecular dysregulations of stomach cancer
    Karthik Balakrishnan et al, 2019, Toxicology in Vitro CrossRef
  45. Corticotropin Releasing Hormone Is Correlated With Tumorigenesis of Gastric Cancer
    Shaobo Yang et al, 2013, Cancer Investigation CrossRef
  46. Risk assessment models of integrative medicine indicators for malignant transformation of chronic atrophic gastritis: A registry study protocol
    Yue Liu et al, 2019, Journal of Traditional Chinese Medical Sciences CrossRef
  47. Exophytic primary gastric squamous cell carcinoma and H. pylori gastritis
    Kehua Zhou et al, 2019, BMJ Case Rep CrossRef
  48. Helicobacter pylori and the gastric microbiota
    Lars Engstrand et al, 2013, Best Practice & Research Clinical Gastroenterology CrossRef
  49. Recent developments in esophageal adenocarcinoma.
    Jesper Lagergren et al, 2013, CA Cancer J Clin CrossRef
  50. Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer
    Gonzalo Carrasco et al, 2013, Gastroenterology Research and Practice CrossRef
  51. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis
    Maryam Akbari et al, 2019, PLoS ONE CrossRef
  52. Managing the changing burden of cancer in Asia
    Rengaswamy Sankaranarayanan et al, 2014, BMC Med CrossRef
  53. null
    Silke Neumann et al, 2019 CrossRef
  54. Seguimiento de las lesiones displásicas o premalignas del tubo digestivo
    Laura Carot Bastard et al, 2014, FMC - Formación Médica Continuada en Atención Primaria CrossRef
  55. Gastric mucin expression in first-degree relatives of gastric cancer patients
    Doron Boltin et al, 2014, European Journal of Gastroenterology & Hepatology CrossRef
  56. Risk of Malignancy Associated with a Maternal Family History of Cancer
    Ju Liu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  57. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κB/Snail signaling pathway in human gastric adenocarcinoma
    Yaodong Zhu et al, 2014, BMC Complement Altern Med CrossRef
  58. Extracts of Celastrus orbiculatus exhibit anti-proliferative and anti-invasive effects on human gastric adenocarcinoma cells
    Yao-dong Zhu et al, 2014, Chin. J. Integr. Med. CrossRef
  59. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors
    Xiao-Dan Yu et al, 2015, Journal of Ethnopharmacology CrossRef
  60. Human Microbiome: When a Friend Becomes an Enemy
    Magdalena Muszer et al, 2015, Arch. Immunol. Ther. Exp. CrossRef
  61. Helicobacter pylori Uses the TlpB Receptor To Sense Sites of Gastric Injury
    Hikaru Hanyu et al, 2019, Infect Immun CrossRef
  62. A meta-analysis: The association between interleukin-17 pathway gene polymorphism and gastrointestinal diseases
    Yu-Xing Jiang et al, 2015, Gene CrossRef
  63. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation
    Inés Benedetti et al, 2019, Revista Española de Patología CrossRef
  64. Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II
    Hadrien Charvat et al, 2016, Int. J. Cancer CrossRef
  65. Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability
    Keisuke Toda et al, 2015, Clin Epigenet CrossRef
  66. Positive relationship betweenp42.3gene and inflammation in chronic non-atrophic gastritis
    Ping Chen et al, 2015, Journal of Digestive Diseases CrossRef
  67. The distribution of jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951 genes of Helicobacter pylori in China
    Yanan Gong et al, 2015, BMC Gastroenterol CrossRef
  68. Estimation of Cancer Burden Attributable to Infection in Asia
    He Huang et al, 2015, Journal of Epidemiology CrossRef
  69. Human gastric cancer, Helicobacter pylori and bracken carcinogens: A connecting hypothesis
    Alberto Oliveros-Bastidas et al, 2016, Medical Hypotheses CrossRef
  70. null
    Karen Robinson et al, 2016 CrossRef
  71. null
    Hyuk Yoon, 2016 CrossRef
  72. Binary mixture ofSatureja hortensisandOriganum vulgaresubsp.hirtumessential oils: in vivo therapeutic efficiency againstHelicobacter pyloriinfection
    Maria Harmati et al, 2017, Helicobacter CrossRef
  73. C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation.
    Goncalo Regalo et al, 2016, J Mol Med (Berl) CrossRef
  74. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis
    Xu Wang et al, 2016, Medicine CrossRef
  75. Promising in vitro and in vivo inhibition of multidrug-resistant Helicobacter pylori by linezolid and novel oxazolidinone analogues
    Jingdong Shi et al, 2016, Journal of Global Antimicrobial Resistance CrossRef
  76. Regression of gastric intestinal metaplasia after the eradication of Helicobacter pylori infection in a hospital in Mexico
    Jaime Alberto Sánchez Cuén et al, 2016, Rev Esp Enferm Dig CrossRef
  77. Differences in amino acid frequency in CagA and VacA sequences of Helicobacter pylori distinguish gastric cancer from gastric MALT lymphoma
    Masahiko Hashinaga et al, 2016, Gut Pathog CrossRef
  78. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients
    Steven E. Schumacher et al, 2017, PLoS ONE CrossRef
  79. Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study
    Lyudmila Boyanova et al, 2017, Diagnostic Microbiology and Infectious Disease CrossRef
  80. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma
    Pei-Shih Hung et al, 2017, PLoS ONE CrossRef
  81. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine development
    Nasrin Mirzaei et al, 2017, Critical Reviews in Microbiology CrossRef
  82. Association between polymorphisms of thymidylate synthase gene 5′- and 3′-UTR and gastric cancer risk: meta-analysis
    Ao Mo et al, 2016 CrossRef
  83. Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori
    Hiroshi Ohyama et al, 2019, BMC Gastroenterol CrossRef
  84. Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer
    Wei Pan et al, 2019, Renal Failure CrossRef
  85. Helicobacter pylori Infection, Virulence Genes’ Distribution and Accompanying Clinical Outcomes: The West Africa Situation
    Eric Gyamerah Ofori et al, 2019, BioMed Research International CrossRef
  86. Metal-induced change in catalytic loop positioning in Helicobacter pylori arginase alters catalytic function
    Ankita Dutta et al, 2019 CrossRef
  87. Clinical Outcomes of Metachronous Gastric Cancer after Endoscopic Resection for Early Gastric Cancer
    Jue Lie Kim et al, 2020, Gut and Liver CrossRef
  88. Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide
    Mahsa Jarestan et al, 2020, 3 Biotech CrossRef
  89. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype
    Małgorzata Pucułek et al, 2018, Oncotarget CrossRef
  90. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
    Hailin Li et al, 2016, Oncotarget CrossRef
  91. Estimation of the performance of a risk prediction model for gastric cancer occurrence in Japan: Evidence from a small external population
    Hadrien Charvat et al, 2020, Cancer Epidemiology CrossRef
  92. Helicobacter pylori virulence factors expression affect epigenetic factors leading to gastrointestinal carcinoma
    Al-Alo KZK et al, 2020 CrossRef
  93. Inflammatory responses induced by Helicobacter pylori on the carcinogenesis of gastric epithelial GES‑1 cells
    Jianjun Wang et al, 2019, Int J Oncol CrossRef
  94. Regulation of GKN1 expression in gastric carcinogenesis: A problem to resolve (Review)
    Judit Alarc�n‑Mill�n et al, 2019, Int J Oncol CrossRef
  95. Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cells.
    Linjun Niu et al, 2018, Oncol Lett CrossRef
  96. Curcumin induces expression of 15-hydroxyprostaglandin dehydrogenase in gastric mucosal cells and mouse stomach in vivo: AP-1 as a potential target
    Jeong-Hwa Woo et al, 2020, The Journal of Nutritional Biochemistry CrossRef
  97. Anti-inflammatory and anti-oxidative effect of Korean propolis on Helicobacter pylori-induced gastric damage in vitro
    Moon-Young Song et al, 2020, J Microbiol. CrossRef
  98. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals
    James W. T. Toh et al, 2020, IJMS CrossRef
  99. Gastric cancer: a comprehensive review of current and future treatment strategies
    Rachel E. Sexton et al, 2020, Cancer Metastasis Rev CrossRef
  100. Gastric Stem Cells: Physiological and Pathological Perspectives
    Shiyu Xiao et al, 2020, Front. Cell Dev. Biol. CrossRef
  101. Non-Invasive Early Molecular Detection of Gastric Cancers
    Hiroyuki Yamamoto et al, 2020, Cancers CrossRef
  102. PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA�
    Rocío Bonoso Criado et al, 2020, Rev Esp Enferm Dig CrossRef
  103. Relationship between MTHFR Gene Polymorphisms and Gastrointestinal Tumors Development: Perspective from Eastern Part of Turkey
    Ersoy Öksüz et al, 2020, Journal of Investigative Surgery CrossRef
  104. Predictive Effect of Helicobacter pylori in Gastric Carcinoma Development: Systematic Review and Quantitative Evidence Synthesis
    Laurens Holmes et al, 2021, Medicines CrossRef
  105. Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
    Mousumi Mahapatro et al, 2021, Cells CrossRef
  106. null
    Ramachandra Reddy Pamuru et al, 2020 CrossRef
  107. An evolutionary non-conserved motif in Helicobacter pylori arginase mediates positioning of the loop containing the catalytic residue for catalysis
    Ankita Dutta et al, 2021 CrossRef
  108. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition
    Yaseen Hussain et al, 2021, Med Oncol CrossRef
  109. Laryngeal Helicobacter pylori Infection and Laryngeal Cancer-Case Series and a Systematic Review
    Li-Jen Hsin et al, 2021, Microorganisms CrossRef
  110. Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, Iran
    Farnaz Rasi-Bonab et al, 2021, BMC Res Notes CrossRef
  111. Eremomastax speciosa (Hochst.) Cufod. counteracts the delaying effect of indomethacin on Helicobacter pylori-associated chronic gastric ulcers healing
    Gaël Tchokomeni Siwe et al, 2021, Journal of Ethnopharmacology CrossRef
  112. Frequency of virulence-associated genotypes of Helicobacter pylori and their correlation with clinical outcome and histological parameters in infected patients
    Milad Shahini Shams Abadi et al, 2021, Heliyon CrossRef
  113. Bacteria-mediated cancer therapies: opportunities and challenges
    Meiyang Yang et al, 2021, Biomater. Sci. CrossRef
  114. Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III–IV in the Chinese High-Risk Gastric Cancer Population
    Song Wang et al, 2021, Front. Med. CrossRef
  115. Association of Dietary Cholesterol Intake With Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Observational Studies
    Peng Miao et al, 2021, Front. Nutr. CrossRef
  116. Helicobacter pylori virulence factors and host genetic polymorphisms in a low gastric cancer incidence and high H pylori prevalence country
    Colin J. Rush et al, 2021, GastroHep CrossRef
  117. Characterization and comparison of bacterial communities in benign vocal fold lesions
    Alissa S Hanshew et al, 2014, Microbiome CrossRef
  118. Role of Helicobacter pylori in the triggering and evolution of hemorrhagic gastro‑duodenal lesions
    Dragos Popa et al, 2021, Exp Ther Med CrossRef
  119. Glycosaminoglycan biosynthesis pathway in host genome is associated with Helicobacter pylori infection
    Dingxue Hu et al, 2021, Sci Rep CrossRef
  120. Infection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation
    Samaneh Saberi et al, 2021, Microbial Pathogenesis CrossRef
  121. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis
    Mihret Tilahun et al, 2022, IDR CrossRef
  122. Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers
    Qing-Hua Sun et al, 2022, WJG CrossRef
  123. Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia in North of Iran
    Seyed Mohammad Valizadeh Toosi et al, 2021, Middle East J Dig Dis CrossRef
  124. Comparative genomics analysis of statistically significant genomic islands of Helicobacter pylori strains for better understanding the disease prognosis
    Joyeeta Chakraborty et al, 2022 CrossRef
  125. Caracterización del cáncer gástrico en Guatemala
    V.L. Matta de García et al, 2015, Rev.Cient. CrossRef
  126. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving Steroid Receptor Coactivator Signaling in Gastric Cancer
    Xing Zhang et al, 2022, Gastroenterology CrossRef
  127. Helicobacter pylori infection: A balance between bacteria and host
    Pamela Bucci et al, 2022, Revista Argentina de Microbiología CrossRef
  128. Frequency of Gastrointestinal Diseases Diagnosed on Barium Contrast Studies
    Aneeqa Khalid et al, 2022, PBMJ CrossRef
  129. Regulatory function of DNA methylation mediated lncRNAs in gastric cancer
    Nan Li et al, 2022, Cancer Cell Int CrossRef
  130. Performance of DNA Methylation on the Molecular Pathogenesis of Helicobacter pylori in Gastric Cancer; targeted therapy approach
    Sogand Vahidi et al, 2022, J Pharmacopuncture CrossRef
  131. High serum levels of l-carnitine and citric acid negatively correlated with alkaline phosphatase are detectable in Koreans before gastric cancer onset
    Youngmin Han et al, 2022, Metabolomics CrossRef